Yigal Nochomovitz
Stock Analyst at Citigroup
(2.32)
# 2,504
Out of 4,754 analysts
288
Total ratings
38.16%
Success rate
-0.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintains: Neutral | $206 → $215 | $171.83 | +25.12% | 4 | Feb 20, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $7.91 | +216.06% | 1 | Feb 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $89 → $82 | $42.29 | +93.90% | 21 | Feb 18, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $33 | $5.72 | +476.92% | 1 | Jan 7, 2025 | |
| MRUS Merus | Maintains: Buy | $89 → $97 | $45.47 | +113.33% | 16 | Dec 9, 2024 | |
| APLT Applied Therapeutics | Maintains: Buy | $13 → $8 | $0.46 | +1,643.68% | 10 | Nov 29, 2024 | |
| CRBU Caribou Biosciences | Maintains: Buy | $30 → $6 | $1.07 | +460.75% | 5 | Nov 26, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $37 → $45 | $15.48 | +190.70% | 7 | Nov 19, 2024 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $40 → $49 | $22.37 | +119.04% | 10 | Nov 12, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $63 → $51 | $24.06 | +111.97% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $5.08 | +96.85% | 14 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $18 | $12.74 | +41.29% | 15 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $6.64 | +306.63% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.22 | +63.93% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 → $23 | $19.13 | +20.23% | 4 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $22.03 | +63.41% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $19.13 | +203.19% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $2.64 | +733.33% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $2.28 | +514.04% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.49 | +143.26% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $10.50 | +261.90% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $7.64 | +83.25% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.13 | -6.10% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $21.54 | +57.85% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $31.73 | +108.01% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $36 → $55 | $16.23 | +238.88% | 8 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $15.68 | +206.12% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.21 | +375.06% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $6.06 | +32.01% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.27 | -55.95% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $7.00 | +400.00% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $41.26 | +222.35% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.29 | +2,634.11% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $1.55 | +287.10% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.29 | +1,140.31% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.03 | +870.87% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.10 | +1,361.19% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $5.11 | +761.06% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.09 | +474.16% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.35 | - | 14 | Sep 28, 2021 |
Krystal Biotech
Feb 20, 2025
Maintains: Neutral
Price Target: $206 → $215
Current: $171.83
Upside: +25.12%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $7.91
Upside: +216.06%
CRISPR Therapeutics AG
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $42.29
Upside: +93.90%
EyePoint Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $5.72
Upside: +476.92%
Merus
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $45.47
Upside: +113.33%
Applied Therapeutics
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.46
Upside: +1,643.68%
Caribou Biosciences
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.07
Upside: +460.75%
Syndax Pharmaceuticals
Nov 19, 2024
Maintains: Buy
Price Target: $37 → $45
Current: $15.48
Upside: +190.70%
Rigel Pharmaceuticals
Nov 12, 2024
Maintains: Buy
Price Target: $40 → $49
Current: $22.37
Upside: +119.04%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $24.06
Upside: +111.97%
Nov 4, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $5.08
Upside: +96.85%
Nov 4, 2024
Maintains: Buy
Price Target: $16 → $18
Current: $12.74
Upside: +41.29%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $6.64
Upside: +306.63%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.22
Upside: +63.93%
Sep 27, 2024
Downgrades: Neutral
Price Target: $19 → $23
Current: $19.13
Upside: +20.23%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $22.03
Upside: +63.41%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $19.13
Upside: +203.19%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $2.64
Upside: +733.33%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $2.28
Upside: +514.04%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.49
Upside: +143.26%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $10.50
Upside: +261.90%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $7.64
Upside: +83.25%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.13
Upside: -6.10%
Apr 10, 2024
Initiates: Buy
Price Target: $34
Current: $21.54
Upside: +57.85%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $31.73
Upside: +108.01%
Feb 15, 2024
Downgrades: Neutral
Price Target: $36 → $55
Current: $16.23
Upside: +238.88%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $15.68
Upside: +206.12%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.21
Upside: +375.06%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $6.06
Upside: +32.01%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.27
Upside: -55.95%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $7.00
Upside: +400.00%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $41.26
Upside: +222.35%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.29
Upside: +2,634.11%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $1.55
Upside: +287.10%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.29
Upside: +1,140.31%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.03
Upside: +870.87%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $1.10
Upside: +1,361.19%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $5.11
Upside: +761.06%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.09
Upside: +474.16%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.35
Upside: -